Table 5.
Effect of AFIF on mean contractile frequency of PCSMS after pretreatments of Ach, neostigmine, or atropine (mean ± SD).
| Administration | N | Mean contractile frequency (beat per minute, BPM) | ||
|---|---|---|---|---|
| Acetylcholine chloride | Neostigmine | Atropine | ||
| Pretreatment | 7 | 4.36 ± 1.51 | 5.26 ± 1.48 | 4.11 ± 0.85 |
| AFIF, 3 μg/mL | 7 | 4.43 ± 1.43 | 5.63 ± 2.24 | 4.11 ± 0.70 |
| AFIF, 30 μg/mL | 7 | 4.25 ± 1.49 | 5.04 ± 0.78 | 4.15 ± 0.67 |
| AFIF, 300 μg/mL | 7 | 4.23 ± 1.41 | 4.51 ± 0.60 | 4.18 ± 0.54 |
| AFIF, 3000 μg/mL | 7 | 4.55 ± 1.35 | 4.19 ± 0.39 | 4.28 ± 0.77 |
| AFIF, 6000 μg/mL | 7 | 4.24 ± 1.30 | 4.05 ± 0.88 | 3.48 ± 1.52 |
| AFIF, 10000 μg/mL | 7 | 3.52 ± 2.05 | 3.36 ± 1.59 | 1.37 ± 1.76 |